Global vaccine sales “grew by a healthy 16 percent last year, when sales shot up to $22.1 billion, healthcare market research publisher Kalorama Information reported Friday,” according to Associated Press. Kalorama is also forecasting sales “will rise at a compound annual rate of 9.7 percent during the next five years,” (Johnson, 8/14).
Private Sector Involvement
Lancet Examines Health Workers Lost To International Organizations A Lancet Comment discusses how developing country doctors and nurses who are recruited by in-countryÂ international organizations, research institutions and non-governmental organizations (NGOs) can “prevent government-trained doctors and nurses from contributing to their [national health service] NHS.” The authors write that some of…
“Pharmaceutical companies, once blasted as uncaring or downright greedy for charging thousands of dollars for a year’s worth of AIDS medicines â€¦ in poor countries, lately have been slashing prices and licensing their drugs for free or nominal cost to nonprofits or local manufacturers in the developing world,” Bloomberg BusinessWeek writes in an analysis piece that examines how this trend, combined with a growing capability among aid agencies to distribute drugs, has the potential to increase access to HIV/AIDS drugs worldwide.
Lancet Comment Calls For More Research Into Alcohol Use, HIV According to a Lancet Comment, “alcohol remains conspicuously absent from the larger field of research and programming in HIV and substance use. … Patterns of hazardous alcohol consumption prevail in countries with the most severe HIV epidemics, notably eastern and…
With reports that ongoing negotiations between India and the European Union are expected to end in a free-trade agreement “by the end of August,” Inter Press Service examines concerns among drug manufacturers and exporters over how the agreement might reduce growth in India’s generic medicines industry.
IRIN Examines Global Humanitarian Assistance Report, Maps Percentage Of African Budgets Spent on Health
“[H]umanitarian watchdog Development Initiatives outlines some of the needs, responses and funding trends” in humanitarian aid over the past decade in its 2010 Global Humanitarian Assistance (GHA) report, IRIN writes in an article that examines the organization’s findings.
“Innovation, science [and] technology must again become fundamental components of how we conduct development work,” Secretary of State Hillary Clinton told a “high-level meeting of international development and science experts” last week, reports SciDev.net.
“India, seasoned in the basics of medicine making, is now starting to take on a more mainstream role in the global drug industry, as a result of recent strengthening of patent law here and cost pressures on name-brand drug makers in the West,” the New York Times writes in a piece that examines what the role could mean for the country as well as for the global drug industry.
WHO Director-General Margaret Chan on Tuesday rejected recent criticisms that her decisions to declare H1N1 (swine flu) a pandemic were impacted by her advisers’ link to the pharmaceutical industry, the Associated Press reports.
Bristol-Myers Squibb’s plans this month to close its plant in Meymac, France, that manufactures “the last therapeutic option” for HIV-positive babies has drawn criticism from UNITAID, Reuters reports. In an open letter published in the Lancet (.pdf), UNITAID writes that “[c]losing this factory means that 4,000 to 7,000 babies currently enrolled in treatment plans in developing countries through UNITAID could be left without the medicines they need.”